Wearable technology has become a global phenomenon over the last few years and is highly competitive at the novelty end of the market. dorsaVi
(ASX:DVL), a medical technology company which has developed sophisticated, wireless sensors is revolutionising wearable technology as it enables, for
the first time, many aspects of detailed human movement and position to be accurately captured, quantified and assessed outside a biomechanics lab.
The company listed on the ASX in December 2013 and has established a global sales and marketing team to drive global product adoption across its
three products ViMove, ViPerform and ViSafe. dorsaVi’s products are being used by more than 60 physiotherapy clinics worldwide, at some of the
world’s luminary sporting clubs including 7 AFL clubs, EPL Clubs Manchester United and West Bromich and Sao Paulo Football Club, and with other
clients including Crown Casino, BP and Sodexo. dorsaVi reported a sales revenue of $617,000 for the six months to December 2014, which represents a
72% growth in sales revenue over the six months to December 2013.
dorsaVi is registered and approved for sale in the US, UK/Europe, Australia and New Zealand and there are over 150 devices in the market globally.